title: Biological perspectives: update on newer antipsychotic drugs: are they evidence based?
authors.forename: Norman L
authors.initials: NL
authors.lastname: Keltner
authors.forename: Randy L
authors.initials: RL
authors.lastname: Moore
authors.forename: Joan S
authors.initials: JS
authors.lastname: Grant
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects; D003986:Dibenzocycloheptenes; D019317:Evidence-Based Medicine / Q000639:trends; D006576:Heterocyclic Compounds, 4 or More Rings / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects; D007211:Indoles / Q000009:adverse effects; D054833:Isoindoles / Q000627:therapeutic use*; D007555:Isoxazoles; D007783:Lactones / Q000009:adverse effects; D000069056:Lurasidone Hydrochloride; D010880:Piperidines / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy*; D011725:Pyridines / Q000009:adverse effects; D017366:Serotonin Receptor Agonists / Q000009:adverse effects; D013450:Sulfones / Q000009:adverse effects; D013844:Thiazoles
chemical_list: D014150:Antipsychotic Agents; D052246:Cyclooxygenase 2 Inhibitors; D003986:Dibenzocycloheptenes; D006576:Heterocyclic Compounds, 4 or More Rings; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007211:Indoles; D054833:Isoindoles; D007555:Isoxazoles; D007783:Lactones; D010880:Piperidines; D011725:Pyridines; D017366:Serotonin Receptor Agonists; D013450:Sulfones; D013844:Thiazoles; C116926:rofecoxib; C105050:tegaserod; C086276:cerivastatin; C522667:asenapine; D000069056:Lurasidone Hydrochloride; C081732:iloperidone